ALDA : Analytical, Life Science & Diagnostics Association

2019 Senior Management Conference
Attendees by Company
As of 10/31/19

  • Abcam
    • Cheri Walker, Senior Vice President Corporate Development
  • Agena Bioscience
    • Peter Dansky, Chief Executive Officer
  • Agilent Technologies
    • Eric Gerber, Senior Vice President Strategy & Corporate Development
    • Padraig McDonnell, Vice President & General Manager, Chemistries and Supplies Division
    • Sam Raha, President, Diagnostics and Genomics Group
    • John Sadler, General Manager, Software and Informatics
    • Jacob Thaysen, Senior Vice President, Agilent, and President, Life Sciences & Applied Markets
  • Analytik-Jena 
    • Monde Qhobosheane, President and Chief Executive Officer
  • Artel
    • Kirby Pilcher, President
    • George Rodrigues, Senior Scientific Manager
  • Axion BioSystems, Inc.
    • Thomas O’Brien, President and Chief Executive Officer
  • BD Biosciences
    • Vangie Gonzalez, Senior Vice President, Marketing Life Sciences
    • Stephen Gunstream, Vice President, General Manager Research and Clinical Solutions 
    • Patrick KaltenbachExecutive VP, BD Biosciences & President, BD Life Sciences Segment
  • Beckman Coulter, a Danaher Company
    • Rajan Kapadia, Vice President Business Development and Strategy
    • Greg Milosevich, President
  • Bio-Techne Corporation
    • Kim Kelderman, President, Diagnostics and Genomics
    • Charles Kummeth, President and CEO
    • Kamni Vijay, Vice President and General Manager, Genomics
  • BioTek Instruments, Inc., an Agilent Company
    • Briar Alpert
  • Bruker Corporation
    • Frank Laukien, President and Chief Executive Officer
    • Rohan Thakur, Executive Vice President, Life Science Business Area
  • Corza Health, Inc.
    • Brian Berning, Chief Financial Officer
    • Mark Gardner, Senior Vice President Business Development
    • Luke Marker, Vice President, Business Development
  • Covaris
    • Hamid Khoja, Principal Scientist
  • Creoptix AG
    • Matyas Vegh, Chief Executive Officer
  • Danaher Corporation
    • Ben Beauvalot, Vice President, Business Development and Strategy
    • Rainer Blair, Executive Vice President–Danaher Life Sciences
    • Kevin Chance, Vice President and Group Executive
    • Judit Losonczi, Vice President of Strategy and Business Development, LS Platforms
    • Francois Mandeville, Vice President, Business Development, Danaher Life Sciences
  • Eppendorf Group
    • Thomas Bachmann, Chief Executive Officer
    • Christiane Honisch, Head of Global Business Intelligence and Development
    • Tine Normann Badger, Area Vice President
    • Hans-Christian Stuff, Vice President Corporate Development
    • Eva van Pelt, Chief Commercial Officer and Board Member of Eppendorf Group
  • Eurofins
    • David Morgan, Senior Vice President — Eurofins U.S. Clinical Diagnostics
  • Fluidic Analytics Ltd.
    • Andrew Lynn, Chief Executive Officer
  • Fluidigm Corporation
    • Christopher Linthwaite, President and Chief Executive Officer
  • Formulatrix, Inc.
    • Jeremy Stevenson, President
  • General Automation Lab Technologies Inc.
    • Peter Christey, Chief Executive Officer
  • Hitachi High Technologies America, Inc.
    • Julian Walker, Director, Business Development
  • HNP-Mikrosysteme GmbH
    • Thomas Weisener, Chief Executive Officer
  • HSE AG 
    • Michael Collasius, Chief Executive Officer
    • Konstantin Lutze, Chief Technology Officer
    • Felix Westhoff, Senior Project Manager
  • IDEX Health & Science
    • Michael Straka, Vice President, Strategy and Business Development
  • Illumina, Inc.
    • Mark Van Oene, Senior Vice President and Chief Commercial Officer
  • Intabio
    • Rohit Khanna, Board of Directors
    • Lena Wu, Chief Executive Officer
  • Jueke Systemtechnik GmbH
    • Martin Hovestadt, Chief Executive Officer
  • Magnetic Insight
    • Anna Christensen, President and Chief Executive Officer
    • Patrick Goodwill, Chief Technology Officer
  • MilliporeSigma
    • Klaus Bischoff, Head of Research Business Unit
  • Mission Bio
    • Marcel Roche, Senior Vice President, Finance
  • MOBILion Systems, Inc.
    • Melissa Sherman, Chief Executive Officer
  • NanoString Technologies, Inc.
    • Anna Berdine, Vice President, Marketing
    • David Ghesquiere, Senior Vice President, Business and Corporate Development
    • R. Bradley Gray, President and Chief Executive Officer
  • NanoView Biosciences
    • Jerry Williamson, Chief Executive Officer
  • New England Biolabs, Inc.
    • Andrew Bertera, Executive Director of Marketing
  • Nexcelom Bioscience
    • Peter Li, Chief Executive Officer
    • Jean Qiu, Chief Technology Officer and Founder
  • OncoCell
    • Mark McDonough, President and Chief Executive Officer
  • Pall Corporation, a Danaher Company
    • Jennifer Honeycutt, President
  • PerkinElmer Inc.
    • Prahlad Singh, President & COO
  • Persistent Systems
    • Rahul Patel, Executive VP/General Manager, Healthcare & Life Sciences
    • Joe Paxton, Vice President — Head of Life Science and Healthcare
  • Planet Innovation
    • Troy O’Callaghan, Executive Director
  • Precision NanoSystems, Inc.
    • James Taylor, Chief Executive Officer
  • Promega Corporation
    • William Linton, Chairman and Chief Executive Officer
    • Sara Mann, General Manager, North America
    • Heather Tomlinson, Director, CDx
  • Protein Dynamic Solutions LLC
    • Selena Larkin, Chief Commercial Officer
  • Purigen Biosystems, Inc.
    • Barney Saunders, Chief Executive Officer
  • RareCyte
    • Joseph Victor, Chief Executive Officer
  • Sage Science, Inc.
    • Todd Barbera, Chief Executive Officer
  • Sands Capital Ventures
    • Ian Ratcliffe, Managing Partner
  • Shimadzu Scientific Instruments Inc.
    • Patrick Fromal, Director of Sales
  • SPARK Holland BV
    • Florian van der Hoeven, Director, Business Development
    • Rob van der Knaap, President
  • STRATEC Consumables GmbH
    • Georg Bauer, Senior Vice President Development Consumables
  • STRATEC SE
    • Ralf Griebel, Senior Vice President, Partnering Business
    • Claus Vielsack, Senior Vice President Corporate Product Development
    • Marcus Wolfinger, Chief Executive Officer
  • Strateos, Inc.
    • Mark Fischer-Colbrie, President and Chief Executive Officer
  • TECAN
    • Ulrich Kanter, Executive Vice President, Head of Development & Operations
    • Klaus Lun, Head of Corporate Development
    • Erik Norstroem, Executive Vice President, Head Corporate Development
    • Achim von Leoprechting, Chief Executive Officer
    • Wael Yared, Chief Technology Officer
  • Thermo Fisher Scientific
    • Zachary Antovich, General Manager, Transplant Diagnostics
    • Fred Lowery, Senior Vice President and President, Life Sciences Solutions and Laboratory Products
  • Trajan Scientific & Medical
    • Glenn Clivaz, CEO Trajan Automation
    • Sam Evans, Senior Vice President, Business Development
    • Andrew Gooley, Chief Scientific Officer
    • Stephen Tomisich, Chairman and Group Chief Executive Officer
  • Twist Bioscience
    • Emily Leproust, Chief Executive Officer
    • Jim Thorburn, Chief Financial Officer
  • Ultivue, Inc.
    • Philippe Mourere, Senior Vice President Commercial
    • Michael Natan, Chief Executive Officer
  • Unchained Labs
    • Tim Harkness, Founder and Chief Executive Officer
  • Volpi Group
    • Harald Kraushaar, Director Global Business Development and Marketing
    • Max Kunz, Chief Executive Officer and Owner
  • Waters Corporation
    • Robert Carson, Senior Vice President, Corporate Development
    • Michael Harrington, Senior Vice President, Global Markets
    • Jeffrey Mazzeo, Vice President, Marketing
  • 10x Genomics
    • Bradford Crutchfield, Chief Commercial Officer